Cobalt derivatives as promising therapeutic agents

Bruijnincx, 2008, New trends for metal complexes with anticancer activity, Curr Opin Chem Biol, 12, 197, 10.1016/j.cbpa.2007.11.013 Hambley, 2007, Developing new metal-based therapeutics: challenges and opportunities, Dalton Trans, 4929, 10.1039/b706075k Haas, 2009, Application of metal coordination chemistry to explore and manipulate cell biology, Chem Rev, 109, 4921, 10.1021/cr900134a Meggers, 2009, Targeting proteins with metal complexes, Chem Commun, 1001, 10.1039/b813568a Schwartz, 2001, Herpes simplex virus type 1 entry is inhibited by the cobalt chelate complex CTC-96, J Virol, 75, 4117, 10.1128/JVI.75.9.4117-4128.2001 Chang, 2010, Cobalt complexes as antiviral and antibacterial agents, Pharmaceuticals, 3, 1711, 10.3390/ph3061711 Hall, 2007, Bioreductive activation and drug chaperoning in cobalt pharmaceuticals, Dalton Trans, 3983, 10.1039/b707121c Louie, 1998, A cobalt complex that selectively disrupts the structure and function of zinc fingers, Proc Natl Acad Sci U S A, 95, 6663, 10.1073/pnas.95.12.6663 Takeuchi, 1999, Inhibition of thermolysin and human alpha-thrombin by cobalt(III) Schiff base complexes, Bioorg Med Chem, 7, 815, 10.1016/S0968-0896(98)00272-7 Harney, 2009, Targeted inhibition of Snail family zinc finger transcription factors by oligonucleotide-Co(III) Schiff base conjugate, Proc Natl Acad Sci U S A, 106, 13667, 10.1073/pnas.0906423106 Harney, 2012, Targeted inactivation of Snail family EMT regulatory factors by a Co(III)-Ebox conjugate, PLoS ONE, 7, e32318, 10.1371/journal.pone.0032318 Hurtado, 2012, Specific inhibition of the transcription factor Ci by a cobalt(III) Schiff base-DNA conjugate, Mol Pharm, 9, 325, 10.1021/mp2005577 Leung, 2012, DNA-binding small molecules as inhibitors of transcription factors, Med Res Rev Berg, 2008, Inhibition of transcription factors with small organic molecules, Curr Opin Chem Biol, 12, 464, 10.1016/j.cbpa.2008.07.023 Harney, 2012, Kinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase 2 by a Co(III) Schiff base complex, J Biol Inorg Chem, 17, 853, 10.1007/s00775-012-0902-3 Takeuchi, 1998, Selective inhibition of human alpha-thrombin by cobalt(III) Schiff base complexes, J Am Chem Soc, 120, 8555, 10.1021/ja981191x Dimiza, 2010, Biological evaluation of non-steroidal anti-inflammatory drugs-cobalt(II) complexes, Dalton Trans, 39, 4517, 10.1039/b927472c Dimiza, 2012, Biological evaluation of cobalt(II) complexes with non-steroidal anti-inflammatory drug naproxen, J Inorg Biochem, 107, 54, 10.1016/j.jinorgbio.2011.10.014 Tsiliou, 2012, Cobalt(II) complexes with non-steroidal anti-inflammatory drug tolfenamic acid: structure and biological evaluation, Eur J Med Chem, 48, 132, 10.1016/j.ejmech.2011.12.004 Adewuyi, 2011, Chitosan-cobalt(II) and nickel(II) chelates as antibacterial agents, Int J Biol Macromol, 48, 301, 10.1016/j.ijbiomac.2010.12.004 Patel, 2011, In vitro bacteriostatic and DNA interaction studies of drug-based mixed-ligand complexes of cobalt(II), Med Chem Res, 20, 220, 10.1007/s00044-010-9310-9 Adediji, 2009, Antimalarial mixed ligand metal complexes: synthesis, physicochemical, biological and activities, Int J Phys Sci, 4, 529 Ajibade, 2010, Cobalt(III) complexes of some antimalarial drugs: synthesis, characterization, and in vitro antiprotozoal studies, Synth React Inorg Met, 40, 273, 10.1080/15533171003766691 Sathyadevi, 2012, Synthesis, crystal structure, electrochemistry and studies on protein binding, antioxidant and biocidal activities of Ni(II) and Co(II) hydrazone complexes, Polyhedron, 31, 294, 10.1016/j.poly.2011.09.021 Shreaz, 2011, Antifungal activity of α-methyl trans cinnamaldehyde, its ligand and metal complexes: promising growth and ergosterol inhibitors, Biometals, 24, 923, 10.1007/s10534-011-9447-0 Khatiwora, 2012, Anthelmintic activity of transition metal complexes of some benzamides, Der Pharma Chem, 4, 1264 Ott, 2005, Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: studies on the mode of drug action, J Med Chem, 48, 622, 10.1021/jm049326z Randaccio, 2010, Vitamin B12: unique metalorganic compounds and the most complex vitamins, Molecules, 15, 3228, 10.3390/molecules15053228 Petrus, 2009, Traveling the Vitamin B12 pathway: oral delivery of protein and peptide drugs, Angew Chem Int Ed Engl, 48, 1022, 10.1002/anie.200800865 Zobi, 2012, 17 e− rhenium dicarbonyl CO-releasing molecules on a cobalamin scaffold for biological application, Dalton Trans, 41, 370, 10.1039/C1DT10649J Ruiz-Sanchez, 2011, Vitamin B12 as a carrier for targeted platinum delivery: in vitro cytotoxicity and mechanistic studies, J Biol Inorg Chem, 16, 33, 10.1007/s00775-010-0697-z Ott, 2009, Modulation of the biological properties of aspirin by formation of a bioorganometallic derivative, Angew Chem Int Ed Engl, 48, 1160, 10.1002/anie.200803347 Ott, 2005, Synthesis, cytotoxicity, cellular uptake and influence on eicosanoid metabolism of cobalt-alkyne modified fructoses in comparison to auranofin and the cytotoxic COX inhibitor Co-ASS, Org Biomol Chem, 3, 2282, 10.1039/b504294c Rubner, 2010, Synthesis and biological activities of transition metal complexes based on acetylsalicylic acid as neo-anticancer agents, J Med Chem, 53, 6889, 10.1021/jm101019j Graf, 2012, Redox activation of metal-based prodrugs as a strategy for drug delivery, Adv Drug Deliv Rev, 64, 993, 10.1016/j.addr.2012.01.007 Jungwirth, 2011, Anticancer activity of metal complexes: involvement of redox processes, Antioxid Redox Signal, 15, 1085, 10.1089/ars.2010.3663 Schafer, 2001, Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple, Free Radic Biol Med, 30, 1191, 10.1016/S0891-5849(01)00480-4 Milbank, 2009, Synthesis and evaluation of stable bidentate transition metal complexes of 1-(chloromethyl)-5-hydroxy-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinoline (seco-6-azaCBI-TMI) as hypoxia selective cytotoxins, J Med Chem, 52, 6822, 10.1021/jm9008746 Wilson, 2011, Targeting hypoxia in cancer therapy, Nat Rev Cancer, 11, 393, 10.1038/nrc3064 Tomco, 2011, Effects of tethered ligands and of metal oxidation state on the interactions of cobalt complexes with the 26S proteasome, J Inorg Biochem, 105, 1759, 10.1016/j.jinorgbio.2011.09.013 Tomco, 2012, Probing chemical reduction in a cobalt(III) complex as a viable route for the inhibition of the 20S proteasome, Inorg Chim Acta, 393, 269, 10.1016/j.ica.2012.06.020 Ware, 2000, Synthesis, structures and hypoxia-selective cytotoxicity of cobalt(III) complexes containing tridentate amine and nitrogen mustard ligands, J Chem Soc Dalton Trans, 925, 10.1039/a909447d Ware, 1997, [N,N-Bis(2-chloroethyl)-1,2-ethanediamine-N,N′]bis(3-methyl-2,4-pentanedionato-O,O′)cobalt(III) perchlorate: a potential hypoxia selective anticancer agent, Acta Crystallogr C, C53, 1058, 10.1107/S0108270197004186 Ware, 1997, Bis-tropolonato derivatives of cobalt(III) complexes of bidentate aliphatic nitrogen mustards as potential hypoxia-selective cytotoxins, J Inorg Biochem, 68, 215, 10.1016/S0162-0134(97)00090-1 Ware, 1991, Design and synthesis of cobalt(III) nitrogen mustard complexes as hypoxia selective cytotoxins. The X-ray crystal structure of bis(3-chloropentane-2,4-dionato)(RS-N,N′-bis(2-chloroethyl)ethylenediamine)cobalt(III) perchlorate, [Co(Clacac)2(bce)]ClO4, J Chem Soc Chem Commun, 1171, 10.1039/C39910001171 Ahn, 2006, Radiolytic and cellular reduction of a novel hypoxia-activated cobalt(III) prodrug of a chloromethylbenzindoline DNA minor groove alkylator, Biochem Pharmacol, 71, 1683, 10.1016/j.bcp.2006.03.007 Ahn, 2004, Optimization of the auxiliary ligand shell of cobalt(III)(8-hydroxyquinoline) complexes as model hypoxia-selective radiation-activated prodrugs, Radiat Res, 162, 315, 10.1667/RR3229 Failes, 2007, Studies of a Co(III) complex of the MMP inhibitor marimastat: a potential hypoxia activated prodrug, Chem: Eur J, 13, 2974, 10.1002/chem.200601137 Wilson, 1994, Exploiting tumor hypoxia through bioreductive release of diffusible cytotoxins: the cobalt(III)-nitrogen mustard complex SN 24771, Int J Radiat Oncol, 29, 323, 10.1016/0360-3016(94)90283-6 Yamamoto, 2008, Cellular uptake and distribution of cobalt complexes of fluorescent ligands, J Biol Inorg Chem, 13, 861, 10.1007/s00775-008-0374-7 Kim, 2011, Visualising the hypoxia selectivity of cobalt(III) prodrugs, Chem Sci, 2, 2135, 10.1039/c1sc00337b Kozisek, 2008, Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance, J Med Chem, 51, 4839, 10.1021/jm8002334 Rezácová, 2009, Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranes, J Med Chem, 52, 7132, 10.1021/jm9011388 Seo, 2006, FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents, Nat Mater, 5, 971, 10.1038/nmat1775 Fortin, 2007, Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia, J Am Chem Soc, 129, 2628, 10.1021/ja067457e Saha, 2010, Enhanced photodynamic effect of cobalt(III) dipyridophenazine complex on thyrotropin receptor expressing HEK293 cells, Metallomics, 2, 754, 10.1039/c0mt00028k Sun, 2011, A new Co(III)-hypocrellin B complex with enhanced photonuclease activity, J Inorg Biochem, 105, 978, 10.1016/j.jinorgbio.2011.03.021 Roy, 2011, Cobalt(II) complexes of terpyridine bases as photochemotherapeutic agents showing cellular uptake and photocytotoxicity in visible light, Dalton Trans, 40, 1233, 10.1039/C0DT00223B Kawade, 2011, Mixed ligand cobalt(II) picolinate complexes: synthesis, characterization, DNA binding and photocleavage, Dalton Trans, 40, 639, 10.1039/C0DT01078B Nagababu, 2011, Synthesis, characterization, DNA binding properties, fluorescence studies and toxic activity of cobalt(III) and ruthenium(II) polypyridyl complexes, J Fluoresc, 21, 563, 10.1007/s10895-010-0743-9